197

Drug Discovery
Sub Categories on Drug Discovery
Latest Articles
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.
High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat